Ibex Investors’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-9,011
Closed -$209K 96
2019
Q1
$209K Buy
+9,011
New +$209K 0.02% 46